Skip to main content
Clinical Trials/NCT04394520
NCT04394520CompletedNot Applicable

A Randomized Controlled Trial of Varying Consent Language and Mode to Improve Interactive Voice Response (IVR) Survey Performance in Colombia and Uganda

Johns Hopkins Bloomberg School of Public Health2 sites in 2 countries3,786 target enrollmentStarted: August 31, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
3,786
Locations
2
Primary Endpoint
Cooperation Rate #1

Study Overview

Brief Summary

This study evaluates the effect of one new form of introduction language and three new modes of providing consent on interactive voice response (IVR) survey cooperation, response, refusal and contact rates, as compared to control group, in Colombia and Uganda.

Detailed Description

Using random digit dialing (RDD) sampling technique, RDD participants will be randomized to one of five introduction and consent combinations and then have them complete noncommunicable disease risk factor survey with an additional module regarding their understanding of the survey and of its voluntariness. This mobile phone survey will be sent as an interactive voice response (IVR). In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions. (i.e. If you are male, press 1; If you are female, press 2). This study will be conducted in both Colombia and Uganda.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Access to a mobile phone
  • •Greater or equal to 18 years of age
  • •In Colombia, conversant in the Spanish language. In Uganda, conversant in Luo, Luganda, Runyakitara or English languages.

Exclusion Criteria

  • •Less than 18 years of age

Arms & Interventions

Modified Intro, Active Opt-out

Experimental

Modified introductory language will be used, and the consent mode will be changed to active opt-out only.

Intervention: Modified Introduction (Other)

Control

No Intervention

No change will be made to the introduction content or the consent mode (active opt-in and active opt-out) from other related trials

Modified Intro, Standard Consent

Experimental

Modified introductory language will be used, but the consent structure (active opt-in and active opt-out) will remain the same.

Intervention: Modified Introduction (Other)

Modified Intro, Active Opt-in

Experimental

Modified introductory language will be used, and the consent mode will be changed to active opt-in only.

Intervention: Modified Introduction (Other)

Modified Intro, Active Opt-in

Experimental

Modified introductory language will be used, and the consent mode will be changed to active opt-in only.

Intervention: Active Opt-in (Other)

Modified Intro, Active Opt-out

Experimental

Modified introductory language will be used, and the consent mode will be changed to active opt-out only.

Intervention: Active Opt-out (Other)

Modified Intro, Passive Opt-in

Experimental

Modified introductory language will be used, and the consent mode will be changed to passive opt-in only.

Intervention: Modified Introduction (Other)

Modified Intro, Passive Opt-in

Experimental

Modified introductory language will be used, and the consent mode will be changed to passive opt-in only.

Intervention: Passive Opt-in (Other)

Outcomes

Primary Outcomes

Cooperation Rate #1

Time Frame: Through study completion, an average of one month

As defined by American Association for Public Opinion Research, the number of complete interviews divided by the number of complete interviews, partial interviews, refusals and breakoffs.

Response Rate #4

Time Frame: Through study completion, an average of one month

As defined by American Association for Public Opinion Research, the number of complete and partial interviews divided by the number of complete interviews, partial interviews, refusals, breakoffs and the estimated eligible proportion of unknowns.

Secondary Outcomes

  • Refusal Rate #2(Through study completion, an average of one month)
  • Contact Rate #2(Through study completion, an average of one month)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials